[2-[(2S)-1-[2-[(3-methoxyphenyl)methyl-[[4-(1H-pyrazol-4-yl)phenyl]carbamoyl]amino]ethoxy]-1-oxopropan-2-yl]oxy-2-oxoethyl] 4-[2-[(5-bromoquinoxalin-6-yl)amino]-4,5-dihydroimidazol-1-yl]-4-oxobutanoate

C40H40BrN9O9 — CID 146351407

IUPAC[2-[(2S)-1-[2-[(3-methoxyphenyl)methyl-[[4-(1H-pyrazol-4-yl)phenyl]carbamoyl]amino]ethoxy]-1-oxopropan-2-yl]oxy-2-oxoethyl] 4-[2-[(5-bromoquinoxalin-6-yl)amino]-4,5-dihydroimidazol-1-yl]-4-oxobutanoate
SMILESCOc1cccc(CN(CCOC(=O)[C@H](C)OC(=O)COC(=O)CCC(=O)N2CCN=C2Nc2ccc3nccnc3c2Br)C(=O)Nc2ccc(-c3cn[nH]c3)cc2)c1
InChIInChI=1S/C40H40BrN9O9/c1-25(59-35(53)24-58-34(52)13-12-33(51)50-17-16-44-39(50)48-31-10-11-32-37(36(31)41)43-15-14-42-32)38(54)57-19-18-49(23-26-4-3-5-30(20-26)56-2)40(55)47-29-8-6-27(7-9-29)28-21-45-46-22-28/h3-11,14-15,20-22,25H,12-13,16-19,23-24H2,1-2H3,(H,44,48)(H,45,46)(H,47,55)/t25-/m0/s1
InChIKeyMCQNVLQKAZBKBO-VWLOTQADSA-N
MW870.72 g/mol
LogP4.93
Rot. Bonds16

About [2-[(2S)-1-[2-[(3-methoxyphenyl)methyl-[[4-(1H-pyrazol-4-yl)phenyl]carbamoyl]amino]ethoxy]-1-oxopropan-2-yl]oxy-2-oxoethyl] 4-[2-[(5-bromoquinoxalin-6-yl)amino]-4,5-dihydroimidazol-1-yl]-4-oxobutanoate

[2-[(2S)-1-[2-[(3-methoxyphenyl)methyl-[[4-(1H-pyrazol-4-yl)phenyl]carbamoyl]amino]ethoxy]-1-oxopropan-2-yl]oxy-2-oxoethyl] 4-[2-[(5-bromoquinoxalin-6-yl)amino]-4,5-dihydroimidazol-1-yl]-4-oxobutanoate (PubChem CID 146351407) has the molecular formula C40H40BrN9O9 and a molecular weight of 870.72 g/mol. Its IUPAC name is [2-[(2S)-1-[2-[(3-methoxyphenyl)methyl-[[4-(1H-pyrazol-4-yl)phenyl]carbamoyl]amino]ethoxy]-1-oxopropan-2-yl]oxy-2-oxoethyl] 4-[2-[(5-bromoquinoxalin-6-yl)amino]-4,5-dihydroimidazol-1-yl]-4-oxobutanoate.

Molecular Properties

Compound Name[2-[(2S)-1-[2-[(3-methoxyphenyl)methyl-[[4-(1H-pyrazol-4-yl)phenyl]carbamoyl]amino]ethoxy]-1-oxopropan-2-yl]oxy-2-oxoethyl] 4-[2-[(5-bromoquinoxalin-6-yl)amino]-4,5-dihydroimidazol-1-yl]-4-oxobutanoate
PubChem CID146351407
Molecular FormulaC40H40BrN9O9
Molecular Weight870.72 g/mol
Exact Mass869.21
IUPAC Name[2-[(2S)-1-[2-[(3-methoxyphenyl)methyl-[[4-(1H-pyrazol-4-yl)phenyl]carbamoyl]amino]ethoxy]-1-oxopropan-2-yl]oxy-2-oxoethyl] 4-[2-[(5-bromoquinoxalin-6-yl)amino]-4,5-dihydroimidazol-1-yl]-4-oxobutanoate
SMILESCOc1cccc(CN(CCOC(=O)[C@H](C)OC(=O)COC(=O)CCC(=O)N2CCN=C2Nc2ccc3nccnc3c2Br)C(=O)Nc2ccc(-c3cn[nH]c3)cc2)c1
InChIInChI=1S/C40H40BrN9O9/c1-25(59-35(53)24-58-34(52)13-12-33(51)50-17-16-44-39(50)48-31-10-11-32-37(36(31)41)43-15-14-42-32)38(54)57-19-18-49(23-26-4-3-5-30(20-26)56-2)40(55)47-29-8-6-27(7-9-29)28-21-45-46-22-28/h3-11,14-15,20-22,25H,12-13,16-19,23-24H2,1-2H3,(H,44,48)(H,45,46)(H,47,55)/t25-/m0/s1
InChIKeyMCQNVLQKAZBKBO-VWLOTQADSA-N
XLogP4.93
TPSA219.63 Ų
H-Bond Donors3
H-Bond Acceptors14
Rotatable Bonds16
Heavy Atoms59
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500870.72
LogP ≤ 54.93
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}

Analyze [2-[(2S)-1-[2-[(3-methoxyphenyl)methyl-[[4-(1H-pyrazol-4-yl)phenyl]carbamoyl]amino]ethoxy]-1-oxopropan-2-yl]oxy-2-oxoethyl] 4-[2-[(5-bromoquinoxalin-6-yl)amino]-4,5-dihydroimidazol-1-yl]-4-oxobutanoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [2-[(2S)-1-[2-[(3-methoxyphenyl)methyl-[[4-(1H-pyrazol-4-yl)phenyl]carbamoyl]amino]ethoxy]-1-oxopropan-2-yl]oxy-2-oxoethyl] 4-[2-[(5-bromoquinoxalin-6-yl)amino]-4,5-dihydroimidazol-1-yl]-4-oxobutanoate?
The IUPAC name of [2-[(2S)-1-[2-[(3-methoxyphenyl)methyl-[[4-(1H-pyrazol-4-yl)phenyl]carbamoyl]amino]ethoxy]-1-oxopropan-2-yl]oxy-2-oxoethyl] 4-[2-[(5-bromoquinoxalin-6-yl)amino]-4,5-dihydroimidazol-1-yl]-4-oxobutanoate (CID 146351407) is [2-[(2S)-1-[2-[(3-methoxyphenyl)methyl-[[4-(1H-pyrazol-4-yl)phenyl]carbamoyl]amino]ethoxy]-1-oxopropan-2-yl]oxy-2-oxoethyl] 4-[2-[(5-bromoquinoxalin-6-yl)amino]-4,5-dihydroimidazol-1-yl]-4-oxobutanoate.
What is the SMILES notation for [2-[(2S)-1-[2-[(3-methoxyphenyl)methyl-[[4-(1H-pyrazol-4-yl)phenyl]carbamoyl]amino]ethoxy]-1-oxopropan-2-yl]oxy-2-oxoethyl] 4-[2-[(5-bromoquinoxalin-6-yl)amino]-4,5-dihydroimidazol-1-yl]-4-oxobutanoate?
The canonical SMILES for [2-[(2S)-1-[2-[(3-methoxyphenyl)methyl-[[4-(1H-pyrazol-4-yl)phenyl]carbamoyl]amino]ethoxy]-1-oxopropan-2-yl]oxy-2-oxoethyl] 4-[2-[(5-bromoquinoxalin-6-yl)amino]-4,5-dihydroimidazol-1-yl]-4-oxobutanoate is COc1cccc(CN(CCOC(=O)[C@H](C)OC(=O)COC(=O)CCC(=O)N2CCN=C2Nc2ccc3nccnc3c2Br)C(=O)Nc2ccc(-c3cn[nH]c3)cc2)c1.
What is the InChIKey of [2-[(2S)-1-[2-[(3-methoxyphenyl)methyl-[[4-(1H-pyrazol-4-yl)phenyl]carbamoyl]amino]ethoxy]-1-oxopropan-2-yl]oxy-2-oxoethyl] 4-[2-[(5-bromoquinoxalin-6-yl)amino]-4,5-dihydroimidazol-1-yl]-4-oxobutanoate?
The InChIKey is MCQNVLQKAZBKBO-VWLOTQADSA-N. The full InChI is InChI=1S/C40H40BrN9O9/c1-25(59-35(53)24-58-34(52)13-12-33(51)50-17-16-44-39(50)48-31-10-11-32-37(36(31)41)43-15-14-42-32)38(54)57-19-18-49(23-26-4-3-5-30(20-26)56-2)40(55)47-29-8-6-27(7-9-29)28-21-45-46-22-28/h3-11,14-15,20-22,25H,12-13,16-19,23-24H2,1-2H3,(H,44,48)(H,45,46)(H,47,55)/t25-/m0/s1.
What are the key properties of [2-[(2S)-1-[2-[(3-methoxyphenyl)methyl-[[4-(1H-pyrazol-4-yl)phenyl]carbamoyl]amino]ethoxy]-1-oxopropan-2-yl]oxy-2-oxoethyl] 4-[2-[(5-bromoquinoxalin-6-yl)amino]-4,5-dihydroimidazol-1-yl]-4-oxobutanoate?
[2-[(2S)-1-[2-[(3-methoxyphenyl)methyl-[[4-(1H-pyrazol-4-yl)phenyl]carbamoyl]amino]ethoxy]-1-oxopropan-2-yl]oxy-2-oxoethyl] 4-[2-[(5-bromoquinoxalin-6-yl)amino]-4,5-dihydroimidazol-1-yl]-4-oxobutanoate has a molecular weight of 870.72 g/mol, XLogP of 4.93, 16 rotatable bonds, 3 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for [2-[(2S)-1-[2-[(3-methoxyphenyl)methyl-[[4-(1H-pyrazol-4-yl)phenyl]carbamoyl]amino]ethoxy]-1-oxopropan-2-yl]oxy-2-oxoethyl] 4-[2-[(5-bromoquinoxalin-6-yl)amino]-4,5-dihydroimidazol-1-yl]-4-oxobutanoate is sourced from PubChem (CID 146351407), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).